LOXL1 and liver disorder: Ma et al. showed that the expression of LOXL1 was increased in fibrotic liver diseases, and the knockdown of LOXL1 could inhibit transforming growth factor-β1-mediated proliferation and fibrosis of hepatic stellate cells by affecting the phosphorylation of Smad2/3 [18].